Zoetis Inc. (NYSE:ZTS) declared a quarterly dividend on Thursday, October 5th, RTT News reports. Investors of record on Thursday, November 9th will be given a dividend of 0.105 per share on Friday, December 1st. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Wednesday, November 8th.
Zoetis has raised its dividend by an average of 24.9% per year over the last three years and has increased its dividend every year for the last 3 years. Zoetis has a payout ratio of 17.8% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Zoetis to earn $2.72 per share next year, which means the company should continue to be able to cover its $0.42 annual dividend with an expected future payout ratio of 15.4%.
Shares of Zoetis (ZTS) opened at $69.13 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 2.80 and a quick ratio of 1.95. The stock has a market cap of $33,686.22, a PE ratio of 31.71, a price-to-earnings-growth ratio of 2.02 and a beta of 1.02. Zoetis has a 52-week low of $48.24 and a 52-week high of $70.48.
Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.02. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. Zoetis’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.52 EPS. equities research analysts anticipate that Zoetis will post 2.36 earnings per share for the current year.
A number of brokerages recently issued reports on ZTS. Jefferies Group LLC reissued a “buy” rating on shares of Zoetis in a report on Friday. Morgan Stanley increased their price objective on shares of Zoetis from $61.00 to $70.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. BMO Capital Markets increased their target price on shares of Zoetis from $65.00 to $70.00 and gave the company a “market perform” rating in a research report on Friday, November 3rd. BidaskClub upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. Finally, Stifel Nicolaus restated a “buy” rating and set a $65.00 price objective on shares of Zoetis in a research report on Tuesday, October 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $67.06.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2017/11/12/zoetis-inc-zts-to-issue-quarterly-dividend-of-0-11-on-december-1st.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.